Somerset Trust CO Biogen Inc. Transaction History

Somerset Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$219.29 - $241.72 $30,700 - $33,840	-140 Closed	0 $0
Q1 2019 Apr 09, 2019	BUY	$216.71 - $338.96 $18,203 - $28,472	84 Added 150.0%	140 $33,000
Q4 2018 Jan 22, 2019	BUY	$278.5 - $352.75 $13,368 - $16,932	48 Added 600.0%	56 $17,000
Q3 2018 Oct 15, 2018	BUY	$293.51 - $383.83 $2,348 - $3,070	8 New	8 $3,000

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Somerset Trust CO, based on Form 13F filings with the SEC.

Stay updated on Somerset Trust CO with notifications on news.